Ondine Biomedical Inc (OBI) NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
6.10p
6.60p
15.50p
£17.68 million
6.00p
6.10p
5.13p
n/a
0.50p (7.69%) Previous:
0.50p
404,451
n/a
15,000
Performance
1 week 1W | 5.88% | 1 year 1Y | 25% |
---|---|---|---|
1 month 1M | 5.88% | 2 years 2Y | 78.95% |
3 months 3M | 27.27% | 3 years 3Y | n/a |
6 months 6M | 20% | 5 years 5Y | n/a |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue ($m) | 1.20 | 0.64 |
Profit before tax ($m) | (14.41) | (19.37) |
Adjusted EPS (¢): | (7.00) | (10.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Ondine Biomedical's Steriwave added to NHS Supply Chain
21 June 2024 13:14
-
Ondine reports significant financial growth
24 April 2024 15:09
-
Ondine Biomedical assessing Steriwave with Yorkshire partners
5 March 2024 13:50
-
Ondine Biomedical Reports Robust Growth in H1 2024
30 September 2024 07:07
-
Collaboration advances Steriwave for ICU Market
25 September 2024 07:00
-
Ondine secures C$5 million financing
24 September 2024 07:29
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.